Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and
Duncan Bridgeman Mon, 19 Jul 2010
Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.
The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and John Baker 15 years ago.
